Circulating levels of prolactin are elevated in patients with rheumatoid arthritis: a meta-analysis

References

• Adan N, Guzman-Morales J, Ledesma-Colunga MG, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest. 2013 Sep;123(9):3902–3913. PubMed PMID: 23908112; PubMed Central PMCID: PMCPmc3754268. eng.
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011 Dec 8;365(23):2205–2219. PubMed PMID: 22150039; eng.
   PubMed Web of Science ®Google Scholar
• Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002 May;2(5):364–371. PubMed PMID: 12033742; eng
   PubMed Web of Science ®Google Scholar
• McMurray RW. Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol. 2001 Jun;1(6):995–1008. PubMed PMID: 11407318; eng
   PubMed Web of Science ®Google Scholar
• Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci. 2007 Aug;1109:385–400. PubMed PMID: 17785327; eng.
   PubMed Web of Science ®Google Scholar
• Shelly S, Boaz M, Orbach H. Prolactin and autoimmunity. Autoimmun Rev. 2012 May;11(6–7):A465–A470. PubMed PMID: 22155203; eng
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, Mershon JL, Allen DL, et al. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996 Dec;17(6):639–669. PubMed PMID: 8969972; eng.
   PubMed Web of Science ®Google Scholar
• Vera-Lastra O, Jara LJ, Espinoza LR. Prolactin and autoimmunity. Autoimmun Rev. 2002 Dec;1(6):360–364. PubMed PMID: 12848992; eng
   PubMedGoogle Scholar
• Bole-Feysot C, Goffin V, Edery M, et al. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998 Jun;19(3):225–268. PubMed PMID: 9626554; eng.
   PubMed Web of Science ®Google Scholar
• Trott JF, Schennink A, Petrie WK, et al. Triennial lactation symposium: prolactin: the multifaceted potentiator of mammary growth and function. J Anim Sci. 2012 May;90(5):1674–1686. PubMed PMID: 22205663; eng.
   PubMed Web of Science ®Google Scholar
• Pikwer M, Bergstrom U, Nilsson JA, et al. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis. 2009 Apr;68(4):526–530. PubMed PMID: 18477739; eng.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang J, Zhou W, et al. Breastfeeding and risk of rheumatoid arthritis: a systematic review and meta-analysis. J Rheumatol. 2015 Sep;42(9):1563–1569. PubMed PMID: 26178286; eng.
   PubMed Web of Science ®Google Scholar
• Adab P, Jiang CQ, Rankin E, et al. Breastfeeding practice, oral contraceptive use and risk of rheumatoid arthritis among Chinese women: the Guangzhou biobank cohort study. Rheumatology (Oxford). 2014 May;53(5):860–866. PubMed PMID: 24395920; eng.
   PubMed Web of Science ®Google Scholar
• Berglin E, Kokkonen H, Einarsdottir E, et al. Influence of female hormonal factors, in relation to autoantibodies and genetic markers, on the development of rheumatoid arthritis in northern Sweden: a case-control study. Scand J Rheumatol. 2010 Nov;39(6):454–460. PubMed PMID: 20560812; eng.
   PubMed Web of Science ®Google Scholar
• Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheumatism. 1994 Jun;37(6):808–813. PubMed PMID: 8003052; eng
   PubMedGoogle Scholar
• Ghule S, Dhotre A, Gupta M, et al. Serum prolactin levels in women with rheumatoid arthritis. Biomed Res India. 2013;20(2):115–118.
   Google Scholar
• Jorgensen C, Maziad H, Bologna C, et al. Kinetics of prolactin release in rheumatoid arthritis. Clin Exp Rheumatol. 1995 Nov–Dec;13(6):705–709. PubMed PMID: 8835242; eng
   PubMed Web of Science ®Google Scholar
• Zoli A, Lizzio MM, Ferlisi EM, et al. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol. 2002 Aug;21(4):289–293. PubMed PMID: 12189455; eng.
   PubMed Web of Science ®Google Scholar
• Mateo L, Nolla JM, Bonnin MR, et al. High serum prolactin levels in men with rheumatoid arthritis. J Rheumatol. 1998 Nov;25(11):2077–2082. PubMed PMID: 9818647; eng
   PubMed Web of Science ®Google Scholar
• Eijsbouts AM, van Den Hoogen FH, Laan RF, et al. Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity. Ann Rheum Dis. 2005 Mar;64(3):433–437. PubMed PMID: 15319231; PubMed Central PMCID: PMCPmc1755399. eng.
   PubMed Web of Science ®Google Scholar
• Pool AJ, Whipp BJ, Skasick AJ, et al. Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology (Oxford). 2004 Jan;43(1):43–48. PubMed PMID: 12867581; eng.
   PubMed Web of Science ®Google Scholar
• Nagy E, Chalmers IM, Baragar FD, et al. Prolactin deficiency in rheumatoid arthritis. J Rheumatol. 1991 Nov;18(11):1662–1668. PubMed PMID: 1787486; eng
   PubMed Web of Science ®Google Scholar
• Nakken B, Szodoray P. Accelerated atherosclerosis in rheumatoid arthritis: rationale for mannose-binding lectins? J Rheumatol. 2010 Mar;37(3):482–484. PubMed PMID: 20197564; eng
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002 Jun 15;21(11):1539–1558. PubMed PMID: 12111919; eng.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ (Clin Res Ed). 2003 Sep 6;327(7414):557–560. PubMed PMID: 12958120; PubMed Central PMCID: PMCPmc192859. eng.
   PubMed Web of Science ®Google Scholar
• Borenstein M, Hedges LV, Higgins JP, et al. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010 Apr;1(2):97–111. PubMed PMID: 26061376; eng.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res Ed). 1997 Sep 13;315(7109):629–634. PubMed PMID: 9310563; PubMed Central PMCID: PMCPmc2127453. eng
   PubMed Web of Science ®Google Scholar
• Reyes-Castillo Z, Pereira-Suarez AL, Palafox-Sanchez CA, et al. The extrapituitary prolactin promoter polymorphism is associated with rheumatoid arthritis and anti-CCP antibodies in Mexican population. Gene. 2013 Aug 1;525(1):130–135. PubMed PMID: 23660301; eng.
   PubMed Web of Science ®Google Scholar
• Adachi T, Hattori N, Ishihara T, et al. Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis. Eur J Endocrinol. 2013 Aug;169(2):203–209. PubMed PMID: 23720341; eng.
   PubMed Web of Science ®Google Scholar
• Berczi I, Cosby H, Hunter T, et al. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Br J Rheumatol. 1987 Dec;26(6):433–436. PubMed PMID: 3690137; eng
   PubMedGoogle Scholar
• Tang MW, Koopman FA, Visscher JP, et al. Hormone, metabolic peptide, and nutrient levels in the earliest phases of rheumatoid arthritis-contribution of free fatty acids to an increased cardiovascular risk during very early disease. Clin Rheumatol. 2017 Feb;36(2):269–278. 10.1007/s10067-016-3456-x. PubMed PMID: 27807638; PubMed Central PMCID: PMCPmc5290053. eng
   PubMed Web of Science ®Google Scholar
• Kramer CK, Tourinho TF, de Castro WP, et al. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies. Arch Med Res. 2005 Jan–Feb;36(1):54–58. PubMed PMID: 15777996; eng.
   PubMed Web of Science ®Google Scholar
• Gutierrez MA, Garcia ME, Rodriguez JA, et al. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol. 1999 Feb;26(2):277–281. PubMed PMID: 9972958; eng
   PubMed Web of Science ®Google Scholar
• Iqbal T, Ahmed SDH, Sheikh SI, et al. Serum prolactin: biochemical parameter for assessing disease severity among rheumatoid arthritis and systemic lupus erythematosus. Med Forum Mon. 2017;28(6):57–60.
   Google Scholar
• Gudbjornsson B, Skogseid B, Oberg K, et al. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol. 1996 Apr;23(4):596–602. PubMed PMID: 8730111; eng
   PubMed Web of Science ®Google Scholar
• Qiu HM, Li X. Measurement of prolactin from sera in patients with rheumatoid arthritis. J Dalian Med Univ. 2007;29(03):239–240.
   Google Scholar
• Tak PP, Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheumatism. 2000 Dec;43(12):2619–2633. PubMed PMID: 11145019; eng
   PubMedGoogle Scholar
• Nagafuchi H, Suzuki N, Kaneko A, et al. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol. 1999 Sep;26(9):1890–1900. PubMed PMID: 10493666; eng
   PubMed Web of Science ®Google Scholar
• Ogueta S, Munoz J, Obregon E, et al. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Mol Cell Endocrinol. 2002 Apr 25;190(1–2):51–63. PubMed PMID: 11997178; eng
   PubMed Web of Science ®Google Scholar
• Pereira Suarez AL, Lopez-Rincon G, Martinez Neri PA, et al. Prolactin in inflammatory response. Adv Exp Med Biol. 2015;846:243–264. PubMed PMID: 25472542; eng
   PubMed Web of Science ®Google Scholar
• Draca S. Prolactin as an immunoreactive agent. Immunol Cell Biol. 1995 Dec;73(6):481–483. PubMed PMID: 8713468; eng
   PubMed Web of Science ®Google Scholar
• Tang C, Li Y, Lin X, et al. Prolactin increases tumor necrosis factor alpha expression in peripheral CD14 monocytes of patients with rheumatoid arthritis. Cell Immunol. 2014 Jul;290(1):164–168. PubMed PMID: 24997655; eng.
   PubMed Web of Science ®Google Scholar
• Stevens A, Ray D, Alansari A, et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheumatism. 2001 Oct;44(10):2358–2366. PubMed PMID: 11665977; eng
   PubMedGoogle Scholar
• McMurray RW. Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum. 2001 Aug;31(1):21–32. PubMed PMID: 11503136; eng
   PubMed Web of Science ®Google Scholar
• Grimaldi MG. Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response. Br J Clin Pharmacol. 1981 Oct;12(4):579–581. PubMed PMID: 7295491; PubMed Central PMCID: PMCPmc1401902. eng
   PubMed Web of Science ®Google Scholar
• Ramma W, Ahmed A. Is inflammation the cause of pre-eclampsia? Biochem Soc Trans. 2011 Dec;39(6):1619–1627. PubMed PMID: 22103497; PubMed Central PMCID: PMCPmc3222326. eng
   PubMedGoogle Scholar
• Nakajima R, Ishida M, Kamiya CA, et al. Elevated vasoinhibin derived from prolactin and cathepsin D activities in sera of patients with preeclampsia. Hypertens Res. 2015 Dec;38(12):899–901. PubMed PMID: 26376948; eng.
   PubMed Web of Science ®Google Scholar
• Fojtikova M, Tomasova Studynkova J, Filkova M, et al. Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage. Clin Exp Rheumatol. 2010 Nov–Dec;28(6):849–854. PubMed PMID: 21122264; eng
   PubMed Web of Science ®Google Scholar
• Tang MW, Reedquist KA, Garcia S, et al. The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation. Rheumatology (Oxford). 2016 Dec;55(12):2248–2259. PubMed PMID: 27616146; PubMed Central PMCID: PMCPmc5144667. eng.
   PubMed Web of Science ®Google Scholar